Trace elements status in diabetes mellitus type 2: Possible role of the interaction between molybdenum and copper in the progress of typical complications

Diabetes Research and Clinical Practice

Volumn 91, Issue 3, 2011, Pages 333-341

  Flores, Crescencio Rodríguez ^a   Puga, Mónica Preciado ^a   Wrobel, Katarzyna ^a   Garay Sevilla, Ma Eugenia ^a   Wrobel, Kazimierz ^a  

^a UNIVERSITY OF GUANAJUATO   (Mexico)

Author keywords

Complications; Diabetes mellitus type 2; Inductively coupled plasma mass spectrometry; Trace elements

Indexed keywords

ALUMINUM; ARSENIC; CADMIUM; CHROMIUM; COBALT; COPPER; LEAD; MANGANESE; MERCURY; MOLYBDENUM; NICKEL; SELENIUM; TRACE ELEMENT; VANADIUM; ZINC;

ADULT; AGE DISTRIBUTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MOLECULAR INTERACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRINCIPAL COMPONENT ANALYSIS; RISK ASSESSMENT; STUDENT T TEST; URINALYSIS;

ADULT; COPPER; DATA INTERPRETATION, STATISTICAL; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MOLYBDENUM; TRACE ELEMENTS;

EID: 79952363498     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.12.014     Document Type: Article

References (50)

1. Naqshbandi M., Harris S.B., Esler J.G., Antwi-Nsiah F. Global complication rates of type 2 diabetes in Indigenous peoples: a comprehensive review. Diabetes Res Clin Pract 2008, 82:1-17.
2. Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440:944-948.
3. Roberts C.K., Sindhu K.K. Oxidative stress and metabolic syndrome. Life Sci 2009, 84:705-712.
4. Beckett G.J., Arthur J.R. Selenium and endocrine systems. J Endocrinol 2005, 184:455-465.
5. Zheng Y., Li X.K., Wang Y., Cai L. The role of zinc, copper and iron in the pathogenesis of diabetes and diabetic complications: therapeutic effects by chelators. Hemoglobin 2008, 32:135-145.
6. Wrobel K., Garay-Sevilla M.E., Malacara J.M., Fajardo M.E., Wrobel K. Efect of chromium on glucose tolerance, serum cholesterol and triglyceride levels in occupational exposure to trivalent speciers in type 2 diabetic patients and in control subjects. Trace Elem Electrolytes 1999, 16:199-205.
7. Meyer J.A., Spence D.M. A perspective on the role of metals in diabetes: past findings and possible future directions. Metallomics 2009, 1:32-49.
8. Thompson K.H., Orvig C. Vanadium in diabetes: 100 years from phase 0 to phase I. J Inorg Biochem 2006, 100:1925-1935.
9. Marcason W. What is the latest research on the connection between selenium and diabetes?. J Am Diet Assoc 2008, 108:188-204.
10. Sakurai H., Adachi Y. The pharmacology of the insulinomimetic effect of zinc complexes. Biometals 2005, 18:319-323.
11. Wyness L. Understanding the role of diet in type 2 diabetes prevention. Br J Community Nurs 2009, 14:374-379.
12. Aguilar M.V., Saavedra P., Arrieta F.J., Mateos C.J., Gonzalez M.J., Meseguer I., et al. Plasma mineral content in type-2 diabetic patients and their association with the metabolic syndrome. Ann Nutr Metab 2007, 51:402-406.
13. Valko M., Morris H., Cronin M.T. Metals, toxicity and oxidative stress. Curr Med Chem 2005, 12:1161-1208.
14. Tanaka A., Kaneto H., Miyatsuka T., Yamamoto K., Yoshiuchi K., Yamasaki Y., et al. Role of copper ion in the pathogenesis of type 2 diabetes. Endocr J 2009, 56:699-706.
15. Kornhauser C., Garcia-Ramirez J.R., Wrobel K., Perez-Luque E.L., Garay-Sevilla M.E., Wrobel K. Serum selenium and glutathione peroxidase concentrations in type 2 diabetes mellitus patients. Prim Care Diabetes 2008, 2:81-85.
16. Medici V., Rossaro L., Sturniolo G.C. Wilson disease-a practical approach to diagnosis, treatment and follow-up. Dig Liver Dis 2007, 39:601-609.
17. Aupperle H., Schoon H.A., Frank A. Experimental copper deficiency, chromium deficiency and additional molybdenum supplementation in goats-pathological findings. Acta Vet Scand 2001, 42:311-321.
18. Frank A., Danielsson R., Jones B. The 'mysterious' disease in Swedish moose. Concentrations of trace elements in liver and kidneys and clinical chemistry. Comparison with experimental molybdenosis and copper deficiency in the goat. Sci Total Environ 2000, 249:107-122.
19. Frank A. 'Mysterious' moose disease in Sweden. Similarities to copper deficiency and/or molybdenosis in cattle and sheep. Biochemical background of clinical signs and organ lesions. Sci Total Environ 1998, 209:17-26.
20. Frank A. A review of the " mysterious" wasting disease in Swedish moose (Alces alces L.) related to molybdenosis and disturbances in copper metabolism. Biol Trace Elem Res 2004, 102:143-159.
21. Frank A., Wibom R., Danielsson R. Myocardial cytochrome c oxidase activity in Swedish moose (Alces alces L.) affected by molybdenosis. Sci Total Environ 2002, 290:121-129.
22. Frank A., Sell D.R., Danielsson R., Fogarty J.F., Monnier V.M. A syndrome of molybdenosis, copper deficiency, and type 2 diabetes in the moose population of south-west Sweden. Sci Total Environ 2000, 249:123-131.
23. Afridi H.I., Kazi T.G., Kazi N., Baig J.A., Jamali M.K., Arain M.B., et al. Status of essential trace metals in biological samples of diabetic mother and their neonates. Arch Gynecol Obstet 2009, 280:415-423.
24. Kazi T.G., Afridi H.I., Kazi N., Jamali M.K., Arain M.B., Jalbani N., et al. Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biol Trace Elem Res 2008, 122:1-18.
25. Afridi H.I., Kazi T.G., Kazi N., Jamali M.K., Arain M.B., Jalbani N., et al. Evaluation of status of toxic metals in biological samples of diabetes mellitus patients. Diabetes Res Clin Pract 2008, 80:280-288.
26. Sukumar A., Subramanian R. Relative element levels in the paired samples of scalp hair and fingernails of patients from New Delhi. Sci Total Environ 2007, 372:474-479.
27. Edwards J.R., Prozialeck W.C. Cadmium, diabetes and chronic kidney disease. Toxicol Appl Pharmacol 2009, 238:289-293.
28. Navas-Acien A., Silbergeld E.K., Pastor-Barriuso R., Guallar E. Rejoinder: arsenic exposure and prevalence of type 2 diabetes: updated findings from the National Health Nutrition and Examination Survey, 2003-2006. Epidemiology 2009, 20:816-820. [discussion e811-812].
29. Al-Saleh E., Nandakumaran M., Al-Rashdan I., Al-Harmi J., Al-Shammari M. Maternal-foetal status of copper, iron, molybdenum, selenium and zinc in obese gestational diabetic pregnancies. Acta Diabetol 2007, 44:106-113.
30. Hasan N.A. Effects of trace elements on albumin and lipoprotein glycation in diabetic retinopathy. Saudi Med J 2009, 30:1263-1271.
31. Garay-Sevilla M.E., Regalado J.C., Malacara J.M., Nava L.E., Wrobel K., Castro-Rivas A., et al. Advanced glycosylation end products in skin, serum, saliva and urine and its association with complications of patients with type 2 diabetes mellitus. J Endocrinol Invest 2005, 28:223-230.
32. Serafin Muñoz A.H., Preciado Puga M., Wrobel K., Garay Sevilla M.E., Wrobel K. Micro assay for malondialdehyde in human serum by extraction-spectrophotometry using an internal standard. Microchim Acta 2004, 148:285-291.
33. Cornelis R., Sabbioni E., Van der Venne M.T. Trace element reference values in tissues from inhabitants of the European Community. VII. Review of trace elements in blood, serum and urine of the Belgian population and critical evaluation of their possible use as reference values. Sci Total Environ 1994, 158:191-226.
34. Alimonti A., Bocca B., Mannella E., Petruci F., Zennaro F., Cotichini R., et al. Assessment of reference values for selected elements in a healthy urban population. Ann Ist Super Sanita 2005, 41:181-187.
35. Wilhelm M., Ewers U., Schulz C. Revised and new reference values for some trace elements in blood and urine for human biomonitoring in environmental medicine. Int J Hyg Environ Health 2004, 207:69-73.
36. Serdar M.A., Bakir F., Hasimi A., Celik T., Akin O., Kenar L., et al. Trace and toxic element patterns in nonsmoker patients with noninsulin-dependent diabetes mellitus, impaired glucose tolerance, and fasting glucose. Int J Diabetes Dev Countries 2009, 29:35-40.
37. White M.A., Sabbionia E. Trace element reference values in tissues from inhabitants of the European Union. X. A study of 13 elements in blood and urine of a United Kingdom population. Sci Total Environ 1998, 216:253-270.
38. Alimonti A., Petrucci F., Krachler M., Bocca B., Caroli S. Reference values for chromium, nickel and vanadium in urine of youngsters from the urban area of Rome. J Environ Monit 2000, 2:351-354.
39. Turner A.P., Chen B., Piletsky S.A. In vitro diagnostics in diabetes: meeting the challenge. Clin Chem 1999, 45:1596-1601.
40. Caramori M.L., Fioretto P., Mauer M. Enhancing the predictive value of urinary albumin for diabetic nephropathy. J Am Soc Nephrol 2006, 17:339-352.
41. Verges B. Lipid modification in type 2 diabetes: the role of LDL and HDL. Fundam Clin Pharmacol 2009, 23:681-685.
42. Wens J., Dirven K., Mathieu C., Paulus D., Van Royen P. Quality indicators for type-2 diabetes care in practice guidelines: an example from six European countries. Prim Care Diabetes 2007, 1:17-23.
43. Anderson R.A. Chromium and insulin resistance. Nutr Res Rev 2003, 16:267-275.
44. Sanz-Medel A., Fairman B., Wrobel K. Aluminum and silicon speciation in biological materials of clinical relevance. Element speciation in bioinorganic chemistry 1996, 223-254. John Wiley & Sons, New York. S. Caroli (Ed.).
45. Fenga C., Cacciola A., Martino L.B., Calderaro S.R., Di Nola C., Verzera A., et al. Relationship of blood lead levels to blood pressure in exhaust battery storage workers. Ind Health 2006, 44:304-309.
46. Naithani R. Organoselenium compounds in cancer chemoprevention. Mini Rev Med Chem 2008, 8:657-668.
47. Alvarez H.M., Xue Y., Robinson C.D., Canalizo-Hernandez M.A., Marvin R.G., Kelly R.A., et al. Tetrathiomolybdate inhibits copper trafficking proteins through metal cluster formation. Science 2010, 327:331-334.
48. Ogra Y., Komada Y., Suzuki K.T. Comparative mechanism and toxicity of tetra- and dithiomolybdates in the removal of copper. J Inorg Biochem 1999, 75:199-204.
49. Laurie S.H. Thiomolybdates-simple but very versatile reagents. Eur J Inorg Chem 2000, 2443-2450.
50. Zhang L., Lichtmannegger J., Summer K.H., Webb S., Pickering I.J., George G.N. Tracing copper-thiomolybdate complexes in a prospective treatment for Wilson's disease. Biochemistry 2009, 48:891-897.